About This Calculator

The Naloxone Bolus + Infusion Calculator is a clinical support tool designed for healthcare professionals managing adult patients with opioid toxicity. It determines an appropriate continuous intravenous (IV) infusion rate for naloxone based on the cumulative bolus dose required to reverse respiratory depression. This approach helps maintain adequate spontaneous respiration and prevent renarcotization, which can occur as the initial bolus doses wear off due to naloxone’s short half-life compared to many opioids.

Outputs Explained

Upon entering the required patient data, the calculator provides the following key outputs for administration and infusion pump programming:

• Set Infusion Pump to (mL/hr): The primary result, this is the final calculated rate at which the IV infusion pump should be set to deliver the naloxone solution.
• Required Hourly Dose (mg/hour): This is the target amount of naloxone the patient should receive each hour to maintain reversal, calculated as two-thirds of the total effective bolus dose.
• Infusion Concentration (mg/mL): The final concentration of the prepared IV bag, determined by the amount of naloxone added and the total volume of the IV fluid. This value is used to calculate the infusion rate.
• Preparation & Administration Instructions: A summary of steps for preparing the infusion bag and titrating the dose based on clinical response.

How to Use the Calculator

Follow these steps to ensure accurate calculation of the naloxone infusion rate:

1. Patient Weight: Enter the patient’s weight and select the appropriate unit (kg or lbs). While not used in the primary infusion rate calculation, it is crucial for clinical context and documentation.
2. Total Effective Bolus Dose: Sum all individual naloxone boluses administered to the patient that were required to achieve the desired clinical effect (i.e., adequate spontaneous ventilation). For example, if doses of 0.4 mg, 0.4 mg, and 0.8 mg were given, enter 1.6 mg.
3. Amount of Naloxone to Add: Input the total amount of naloxone (in mg) that will be added to the IV fluid bag. A common starting amount is 2 mg, but this can be adjusted.
4. IV Fluid Bag: Select the volume of the IV fluid bag (e.g., 250 mL, 500 mL, 1000 mL) that the naloxone will be added to.
5. IV Fluid Type: Choose the diluent being used, typically Normal Saline or D5W. This selection is for documentation and preparation instructions and does not alter the numerical calculation.

Dosing Overview

The standard protocol for a naloxone infusion is to administer two-thirds (approximately 67%) of the total initial effective bolus dose each hour. This principle is based on naloxone’s pharmacokinetics, aiming to provide a steady state of opioid antagonism that prevents the patient from returning to a state of respiratory depression as the initial bolus doses are metabolized.

The calculator automates this by calculating the hourly dose (Total Bolus Dose × 0.67) and then dividing it by the prepared infusion’s concentration (mg/mL) to determine the required rate in mL/hour. Constant patient monitoring is essential, as the rate may need to be titrated up or down based on respiratory rate, sedation level, and signs of opioid withdrawal.

Switching and Titration

This tool is intended to guide the transition from initial IV bolus resuscitation to a continuous infusion. It is not designed for switching between different opioid antagonists. The primary “switching” consideration is the ongoing titration of the infusion rate.

• Inadequate Response: If the patient’s respiratory status declines, a re-bolus of naloxone (often 50% of the initial effective dose) may be given, and the infusion rate may be increased.
• Signs of Withdrawal: If the patient develops significant opioid withdrawal symptoms (e.g., agitation, tachycardia, vomiting), the infusion rate should be reduced. The goal is adequate ventilation, not a fully awake and agitated patient.

Managing Breakthrough Narcosis

“Missed dose” is not applicable in the context of a continuous infusion for overdose. The more relevant clinical challenge is managing breakthrough narcosis, where the patient’s respiratory depression returns despite the ongoing infusion. This can occur if the opioid has a very long half-life or if the initial infusion rate is insufficient.

If breakthrough narcosis occurs, administer an additional IV bolus of naloxone and consider increasing the continuous infusion rate. The decision to increase the rate should be based on the patient’s clinical response and the size of the re-bolus required.

Safety Alerts

• Clinical Judgment: This calculator is a support tool and does not replace clinical judgment. All calculations must be independently verified.
• Opioid Withdrawal: Administering naloxone, especially at high doses or rapid rates, can precipitate acute opioid withdrawal syndrome, which can be severe. The goal of therapy is to restore ventilation, not to achieve full reversal of consciousness.
• Short Half-Life: Naloxone’s duration of action (30-90 minutes) is shorter than that of most opioids. Discontinuing the infusion prematurely can lead to recurrent respiratory depression (renarcotization).
• Constant Monitoring: Patients receiving a naloxone infusion require continuous monitoring in an appropriate clinical setting (e.g., ICU, ED) with frequent assessment of respiratory status, level of consciousness, and vital signs.

Frequently Asked Questions

Why is the infusion rate based on two-thirds of the bolus dose?

This is a widely accepted clinical rule of thumb designed to maintain a therapeutic level of naloxone to counteract the ongoing effects of the opioid without inducing severe withdrawal. It provides a starting point for the infusion, which should then be titrated to the individual patient’s response.

Can I use this calculator for pediatric patients?

No. This tool is specifically designed and validated for adult patients. Pediatric dosing for naloxone is different and requires weight-based calculations that are not included in this tool.

What is the “total effective bolus dose”?

It is the cumulative amount of all naloxone boluses required to restore adequate spontaneous breathing. It is not necessarily the total amount given, but the amount that achieved the desired clinical endpoint. For example, if a patient responded after three 0.4 mg doses, the total effective dose is 1.2 mg.

Does the choice of IV fluid (Normal Saline vs. D5W) affect the calculation?

No, the choice of a compatible IV fluid does not change the infusion rate calculation. Naloxone is stable in both 0.9% Sodium Chloride (Normal Saline) and 5% Dextrose in Water (D5W). The option is included to ensure the final instructions are complete.

What should I do if the calculated rate is very high or very low?

Double-check all input values for accuracy, particularly the total effective bolus dose. An unusually high rate may suggest an error in the entered bolus dose or a very low concentration. A very low rate might be appropriate for a patient who required a small bolus dose. Always use clinical judgment to assess if the calculated rate is reasonable.

How long should the naloxone infusion continue?

The duration depends on the half-life of the opioid involved. For long-acting opioids like methadone, an infusion may be needed for 24 hours or longer. The infusion is typically weaned gradually once the patient is stable and the risk of renarcotization is low.

Why does the calculator default to 2 mg of naloxone in a 500 mL bag?

These are common, standard values used in many clinical protocols for preparing a naloxone infusion, resulting in a concentration of 4 mcg/mL. The tool allows these values to be changed to match local pharmacy protocols or available supplies.

What happens if I enter the weight in lbs instead of kg?

The calculator will correctly convert the weight to kilograms for display purposes in the results summary. The patient’s weight is not part of the infusion rate formula itself but is provided for clinical context.

References

1. U.S. Food and Drug Administration (FDA). NALOXONE HYDROCHLORIDE injection prescribing information. Access data on the FDA’s website. Drugs@FDA Database.
2. Panchal AR, Bartos JA, Cabañas JG, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16_suppl_2):S366-S468.
3. Kim HK, Nelson LS. Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. Expert Opin Drug Saf. 2015;14(7):1137-1146.
4. Substance Abuse and Mental Health Services Administration (SAMHSA). SAMHSA Opioid Overdose Prevention Toolkit. HHS Publication No. (SMA) 18-4742. Published 2018.